News & Events

StageBio appoints Dr. Juliana Lee as Interim Director, Medical Device Pathology

StageBio is honored to introduce Dr. Juliana Lee, BVSc, MS, DACVP as Interim Director, Medical Device Pathology.

We are happy to have Juliana in this new role, and we are looking forward to all she will accomplish!

As part of our medical device pathologist team, Dr. Juliana Lee will support StageBio’s mission by:

  • Assisting with development of short- and long-term Division objectives
  • Meeting regularly with Division operations leadership to ensure operational efficiency
  • Providing regular Division updates at Scientific Advisory Committee meetings
  • Maintaining and building internal relationships and foster the team
  • Serving as subject matter expert and provide guidance to Client and/or Study Sponsor to assist in the identification of project scope
  • Interacting with clients as needed to facilitate project development and satisfaction
  • Functioning as Principal Investigator, Study Pathologist, and/or peer review or pathology working group (PWG) pathologist

“Juliana has been stepping forward to represent the device team in StageBio initiatives in multiple instances recently and has consistently illustrated a passion for providing high quality work. She has a wide range of interests and has contributed to studies for the device team, the neuro team, and the investigative path team in the past. I have never known her to shy away from learning something new! I am personally inspired by Juliana and her fervent drive to do her best in any job she takes on, whether it is as a pathologist, team member, leader, or friend. I’m looking forward to collaborating with Juliana in her new role and hope that you will all join me in congratulating and supporting her as she takes on new responsibilities.”

- Kathy Bailey, VP, Specialty Operations

AboutDr. Juliana Lee, Interim Director, Medical Device Pathology

Dr. Lee completed her training in anatomic pathology at the Joint Pathology Center in Silver Spring, Maryland. She is a diplomate of the American College of Veterinary Pathologists and a member of the Society of Toxicologic Pathology. Dr. Lee has a degree in Mechanical Engineering and a master’s degree in Veterinary Pathology with experience in molecular pathology. In addition to her work in pre-clinical studies involving medical devices and neuropathology, she brings a robust enthusiasm for sound science and quality work to any study as a consulting or lead pathologist.

StageBio is committed to our mission of improving lives through high-quality histopathology, diagnostics, and research. Join us in congratulating Dr. Juliana Lee on her new role at StageBio.

The StageBio team is growing! If you are interested in learning more about our current open positions, please visit our careers page here.

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com.

Back to Index

Upcoming Events

ESMO Congress 2022

Date: September 9-13, 2022
Location: Paris, France
The StageBio team is looking forward to attending ESMO Congress 2022 in Paris, France, September 9-13, and we hope to see you there!

Popular Posts

Learn more about StageBio’s COVID-19 response